Karin Schmelz
Berlin, BE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Serially Quantifying TERT Rearrangement Breakpoints in ctDNA Enables Minimal Residual Disease Monitoring in Patients with Neuroblastoma.
Journal: Cancer research communications
Published: November 23, 2024
3R centres contributions to change animal experimentation : A field report from Charité 3R, the 3R centre of a medical faculty.
Journal: EMBO reports
Published: March 28, 2024
Parallel sequencing of extrachromosomal circular DNAs and transcriptomes in single cancer cells.
Journal: Nature genetics
Published: December 20, 2021
Neuroblastoma Risk Assessment and Treatment Stratification with Hybrid Capture-Based Panel Sequencing.
Journal: Journal of personalized medicine
Published: May 14, 2021
X-linked inhibitor of apoptosis protein represents a promising therapeutic target for relapsed/refractory ALL.
Journal: EMBO molecular medicine
Published: May 14, 2021
Spatial and temporal intratumour heterogeneity has potential consequences for single biopsy-based neuroblastoma treatment decisions.
Journal: Nature communications
Published: November 23, 2020
Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.
Journal: The Journal of molecular diagnostics : JMD
Published: March 05, 2020
Publisher Correction: Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.
Journal: Nature genetics
Published: February 29, 2020
Extrachromosomal circular DNA drives oncogenic genome remodeling in neuroblastoma.
Journal: Nature genetics
Published: October 29, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026